420 related articles for article (PubMed ID: 17414670)
1. Inhibition of Rho-kinase attenuates nephrosclerosis and improves survival in salt-loaded spontaneously hypertensive stroke-prone rats.
Nishikimi T; Koshikawa S; Ishikawa Y; Akimoto K; Inaba C; Ishimura K; Ono H; Matsuoka H
J Hypertens; 2007 May; 25(5):1053-63. PubMed ID: 17414670
[TBL] [Abstract][Full Text] [Related]
2. Fasudil, a Rho-kinase inhibitor, reverses L-NAME exacerbated severe nephrosclerosis in spontaneously hypertensive rats.
Koshikawa S; Nishikimi T; Inaba C; Akimoto K; Matsuoka H
J Hypertens; 2008 Sep; 26(9):1837-48. PubMed ID: 18698220
[TBL] [Abstract][Full Text] [Related]
3. Long-term administration of rho-kinase inhibitor ameliorates renal damage in malignant hypertensive rats.
Ishikawa Y; Nishikimi T; Akimoto K; Ishimura K; Ono H; Matsuoka H
Hypertension; 2006 Jun; 47(6):1075-83. PubMed ID: 16636194
[TBL] [Abstract][Full Text] [Related]
4. Fasudil, a Rho-kinase inhibitor, attenuates glomerulosclerosis in Dahl salt-sensitive rats.
Nishikimi T; Akimoto K; Wang X; Mori Y; Tadokoro K; Ishikawa Y; Shimokawa H; Ono H; Matsuoka H
J Hypertens; 2004 Sep; 22(9):1787-96. PubMed ID: 15311108
[TBL] [Abstract][Full Text] [Related]
5. Effect of fasudil on Rho-kinase and nephropathy in subtotally nephrectomized spontaneously hypertensive rats.
Kanda T; Wakino S; Hayashi K; Homma K; Ozawa Y; Saruta T
Kidney Int; 2003 Dec; 64(6):2009-19. PubMed ID: 14633123
[TBL] [Abstract][Full Text] [Related]
6. [Effects of rho-kinase inhibitor on cardiac hypertrophy of left ventricle in spontaneously hypertensive rats].
Zhang ZJ; Fan YF; Zhang ZY; Xie PY; Fang HC; Su YS
Zhonghua Yi Xue Za Zhi; 2012 Dec; 92(48):3438-41. PubMed ID: 23327708
[TBL] [Abstract][Full Text] [Related]
7. Ontogenetic changes in contribution of calcium sensitization and calcium entry to blood pressure maintenance of Wistar-Kyoto and spontaneously hypertensive rats.
Behuliak M; Vavřínová A; Bencze M; Polgárová K; Ergang P; Kuneš J; Vaněčková I; Zicha J
J Hypertens; 2015 Dec; 33(12):2443-54. PubMed ID: 26418671
[TBL] [Abstract][Full Text] [Related]
8. Fasudil improves the endothelial dysfunction in the aorta of spontaneously hypertensive rats.
Tsounapi P; Saito M; Kitatani K; Dimitriadis F; Ohmasa F; Shimizu S; Kinoshita Y; Takenaka A; Satoh K
Eur J Pharmacol; 2012 Sep; 691(1-3):182-9. PubMed ID: 22819709
[TBL] [Abstract][Full Text] [Related]
9. The Rho-kinase inhibitor, fasudil, attenuates diabetic nephropathy in streptozotocin-induced diabetic rats.
Gojo A; Utsunomiya K; Taniguchi K; Yokota T; Ishizawa S; Kanazawa Y; Kurata H; Tajima N
Eur J Pharmacol; 2007 Jul; 568(1-3):242-7. PubMed ID: 17511984
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms and therapeutic strategies of chronic renal injury: renoprotective effect of rho-kinase inhibitor in hypertensive glomerulosclerosis.
Nishikimi T; Matsuoka H
J Pharmacol Sci; 2006 Jan; 100(1):22-8. PubMed ID: 16397372
[TBL] [Abstract][Full Text] [Related]
11. Involvements of Rho-kinase and TGF-beta pathways in aldosterone-induced renal injury.
Sun GP; Kohno M; Guo P; Nagai Y; Miyata K; Fan YY; Kimura S; Kiyomoto H; Ohmori K; Li DT; Abe Y; Nishiyama A
J Am Soc Nephrol; 2006 Aug; 17(8):2193-201. PubMed ID: 16790507
[TBL] [Abstract][Full Text] [Related]
12. Long-term inhibition of Rho kinase with fasudil attenuates high flow induced pulmonary artery remodeling in rats.
Li F; Xia W; Li A; Zhao C; Sun R
Pharmacol Res; 2007 Jan; 55(1):64-71. PubMed ID: 17127075
[TBL] [Abstract][Full Text] [Related]
13. Vasodilator effects of fasudil, a Rho-kinase inhibitor, on retinal arterioles in stroke-prone spontaneously hypertensive rats.
Okamura N; Saito M; Mori A; Sakamoto K; Kametaka S; Nakahara T; Ishii K
J Ocul Pharmacol Ther; 2007 Jun; 23(3):207-12. PubMed ID: 17593003
[TBL] [Abstract][Full Text] [Related]
14. Ca2+ sensitization and Ca2+ entry in the control of blood pressure and adrenergic vasoconstriction in conscious Wistar-Kyoto and spontaneously hypertensive rats.
Behuliak M; Pintérová M; Bencze M; Petrová M; Líšková S; Karen P; Kuneš J; Vaněčková I; Zicha J
J Hypertens; 2013 Oct; 31(10):2025-35. PubMed ID: 24107733
[TBL] [Abstract][Full Text] [Related]
15. Chimeric DNA-RNA hammerhead ribozyme targeting transforming growth factor-beta1 mRNA ameliorates renal injury in hypertensive rats.
Tahira Y; Fukuda N; Endo M; Ueno T; Matsuda H; Saito S; Matsumoto K; Mugishima H
J Hypertens; 2007 Mar; 25(3):671-8. PubMed ID: 17278984
[TBL] [Abstract][Full Text] [Related]
16. Renoprotective effects of carvedilol in hypertensive-stroke prone rats may involve inhibition of TGF beta expression.
Wong VY; Laping NJ; Nelson AH; Contino LC; Olson BA; Gygielko E; Campbell WG; Barone F; Brooks DP
Br J Pharmacol; 2001 Nov; 134(5):977-84. PubMed ID: 11682445
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of rho kinase attenuates high flow induced pulmonary hypertension in rats.
Li FH; Xia W; Li AW; Zhao CF; Sun RP
Chin Med J (Engl); 2007 Jan; 120(1):22-9. PubMed ID: 17254483
[TBL] [Abstract][Full Text] [Related]
18. Effects of Rho-kinase inactivation on eosinophilia and hyper-reactivity in murine airways by allergen challenges.
Taki F; Kume H; Kobayashi T; Ohta H; Aratake H; Shimokata K
Clin Exp Allergy; 2007 Apr; 37(4):599-607. PubMed ID: 17430358
[TBL] [Abstract][Full Text] [Related]
19. Rho kinase activation and gene expression related to vascular remodeling in normotensive rats with high angiotensin I converting enzyme levels.
Rivera P; Ocaranza MP; Lavandero S; Jalil JE
Hypertension; 2007 Oct; 50(4):792-8. PubMed ID: 17785632
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of hydroxyfasudil, a Rho kinase inhibitor, on ventral prostatic hyperplasia in the spontaneously hypertensive rat.
Holmström F; Shimizu S; Shimizu T; Higashi Y; Martin DT; Honda M; Saito M
Prostate; 2015 Nov; 75(15):1774-82. PubMed ID: 26286428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
